Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the visceral pain market?

The visceral pain market has grown strongly in recent years, anticipated to rise from $13.84 billion in 2024 to $14.87 billion in 2025 at a CAGR of 7.5%. Key drivers of historical growth include an aging population, increased prevalence of chronic diseases, medical research advancements, healthcare infrastructure expansion, and higher awareness and diagnosis rates.

What will be the visceral pain market size in the future?

The visceral pain market is projected to see strong growth, reaching $18.71 billion by 2029, with a CAGR of 5.9%. Growth will be driven by technological innovations in pain management, increased demand for non-invasive treatments, emerging market opportunities, and digital health integration. Key trends include multimodal pain management, alternative therapies, targeted treatments, AI-driven pain assessment, and telemedicine-based solutions.

Get your visceral pain market report here!

https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

What main drivers are fueling expansion in the visceral pain market?

The growing need for painkillers is believed to be a key driver for the burgeoning visceral pain market. These painkillers, known as analgesics, work by reducing or inhibiting the sensation of pain in the brain, effectively managing visceral pain which originates from the internal organs by targeting the nervous system. Interestingly, by April 2024, it was reported by the UK’s weekly medical journal, the New England Journal of Medicine that the number of clinicians prescribing buprenorphine had significantly increased to over 53,600, a jump of 11,500 from the previous year, December 2022. Consequently, this escalating demand for analgesics is significantly contributing to the expansion of the visceral pain market.

What key areas define the segmentation of the global visceral pain market?

The visceral pain market covered in this report is segmented –

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs

3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

Who are the dominant players expanding their reach in the visceral pain market?

Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

How are evolving market trends shaping visceral pain Strategies?

Leading firms in the visceral pain market are pursuing the development of novel products such as NHE3 Inhibitors, in a bid to deliver dependable services to their clientele. These inhibitors constitute a medicinal category that functions by restraining the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. For example, Ardelyx, a pioneering biopharmaceutical establishment stationed in the United States, introduced an NHE3 Inhibitor medicine, IBSRELA, in April 2022. IBSRELA signifies a groundbreaking therapy for irritable bowel syndrome with constipation (IBS-C) adults, operating through the inhibition of Sodium-Hydrogen Exchanger 3 (NHE3) in both the small intestine and colon. Animal studies have demonstrated that it significantly reduces abdominal pain by mitigating visceral hypersensitivity and intestinal permeability.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13950

Which regions are emerging as leaders in the visceral pain market?

North America was the largest region in the visceral pain market in 2024. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Painting And Wall Covering Contractors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/painting-and-wall-covering-contractors-global-market-report

Pain Management Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: